Kerry Nie
Surgical · Dayton, OHNPI 1780770057
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 256 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 25 manufacturers, the largest accounting for just 17.0% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2024 at $1,857 and has fallen 55.1% since, to $833 in 2025. Among surgical clinicians in OH with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 256 payments — averaging $26.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$856
- Esperion Therapeutics, Inc.$830
- AstraZeneca$823
- Amgen$578
- GSK$555
- plus $2K from 19 others
What the payments were for
- Food & beverage$6,797100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 38 | $1,157 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 42 | $856 |
| Esperion Therapeutics, Inc. | 33 | $830 |
| AstraZeneca | 23 | $823 |
| Amgen(2 entities) | 25 | $578 |
| GSK | 21 | $555 |
| Gilead | 19 | $419 |
| IBSA Pharma Inc. | 4 | $274 |
| Ironwood Pharmaceuticals, Inc | 13 | $253 |
| Bayer | 5 | $207 |
| Amarin Pharma, Inc. | 11 | $207 |
| Phathom Pharmaceuticals, Inc. | 1 | $150 |
| Exact Sciences | 3 | $77 |
| Boehringer Ingelheim | 3 | $64 |
| Aimmune Therapeutics, Inc. | 2 | $62 |
| Merck | 3 | $55 |
| Nestle Healthcare Nutrition Inc. | 2 | $45 |
| Ardelyx, Inc. | 1 | $28 |
| Vanda Pharmaceuticals Inc. | 1 | $28 |
| Pfizer | 1 | $26 |
| Lilly USA, LLC | 1 | $25 |
| Eyevance Pharmaceuticals LLC | 1 | $23 |
| Hikma Pharmaceuticals USA | 1 | $23 |
| Seqirus USA Inc | 1 | $18 |
| Novo Nordisk | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$6,797 in reported general payments places this provider in the 95th percentile of 294 surgical providers in Ohio.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| VascepaIcosapent Ethyl | 979 | $361,538 |
| Diclofenac Epolamine | 388 | $168,811 |
| Clemastine Fumarate | 41 | $112,843 |
| LinzessLinaclotide | 179 | $96,746 |
| NexletolBempedoic Acid | 222 | $90,716 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 113 | $71,616 |
| Diclofenac Sodium | 176 | $62,491 |
| JanuviaSitagliptin Phosphate | 94 | $54,118 |
| Omeprazole-Sodium BicarbonateOmeprazole/Sodium Bicarbonate | 52 | $48,233 |
| XifaxanRifaximin | 21 | $46,114 |
| XareltoRivaroxaban | 83 | $45,914 |
| JardianceEmpagliflozin | 69 | $43,016 |
| OzempicSemaglutide | 41 | $37,758 |
| TrulancePlecanatide | 63 | $36,867 |
| FarxigaDapagliflozin Propanediol | 60 | $36,741 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieLinzess, Creon | $1,157 | $127,318229 claims |
| AstraZenecaBreztri Aerosphere, Farxiga, Nexium | $823 | $114,236195 claims |
| MerckJanuvia, Janumet Xr, Janumet | $55 | $108,082197 claims |
| Esperion Therapeutics, Inc.Nexletol, Nexlizet | $830 | $104,809259 claims |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLCXifaxan, Trulance | $856 | $82,98184 claims |
| Novo NordiskOzempic, Rybelsus | $15 | $54,04758 claims |
| GileadVemlidy, Viread | $419 | $48,75338 claims |
| Boehringer IngelheimJardiance | $64 | $43,01669 claims |
| AmgenEvenity (2 Syringes) | $578 | $28,64412 claims |
| GSKTrelegy Ellipta | $555 | $23,02135 claims |
| IBSA Pharma Inc.Licart | $274 | $20,62324 claims |
| PfizerAbrysvo | $26 | $8,81231 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 294 surgical providers in Ohio.
Other surgical in Dayton
- Anne KrogerDayton$10K
- Joanne MoffDayton$2K
- Andrew BakerColumbus$102K
- Michael KuehneToledo$35K
- Joseph EhrhardCincinnati$14K
- Leigha GarringerColumbus$13K
- Brian StevensLorain$13K
- James SabettaAkron$9K
- Monica SedmakCincinnati$7K
- Megan WhitehouseCincinnati$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.